Skip to main content
. 2021 Jun 10;12:338. doi: 10.1186/s13287-021-02410-w

Fig. 4.

Fig. 4

ADSC-Exos inhibits inflammatory expression in tendon injury. a–d The expression of CCR7+, CD163+, IL-6+, and IL-10+ cells were detected by immunofluorescence at week 1. e Positive ratio of inflammation-related factors (n = 6). Bars, 50 μm. Data are represented as mean ± SD. *vs control group; #vs GelMA group. **P < 0.01, ***P < 0.001, ****P < 0.0001, ###P < 0.001, ####P < 0.0001

HHS Vulnerability Disclosure